ID

33909

Description

Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma (CLARION); ODM derived from: https://clinicaltrials.gov/show/NCT01818752

Link

https://clinicaltrials.gov/show/NCT01818752

Keywords

  1. 1/7/19 1/7/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 7, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT01818752

Eligibility Multiple Myeloma NCT01818752

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed symptomatic multiple myeloma
Description

Multiple Myeloma Symptomatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0231220
transplant-ineligibility
Description

Ineligibility Transplantation

Data type

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0040732
males and females ≥ 18 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
left ventricular ejection fraction (lvef) ≥ 40%
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
waldenstrom macroglobulinemia
Description

Waldenstrom Macroglobulinemia

Data type

boolean

Alias
UMLS CUI [1]
C0024419
known amyloidosis
Description

Amyloidosis

Data type

boolean

Alias
UMLS CUI [1]
C0002726
plasma cell leukemia
Description

Leukemia, Plasma Cell

Data type

boolean

Alias
UMLS CUI [1]
C0023484
poems syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes)
Description

POEMS Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0085404
significant neuropathy (grades ≥ 2) within 14 days prior to randomization
Description

Neuropathy CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728

Similar models

Eligibility Multiple Myeloma NCT01818752

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Myeloma Symptomatic
Item
newly diagnosed symptomatic multiple myeloma
boolean
C0026764 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Ineligibility Transplantation
Item
transplant-ineligibility
boolean
C1512714 (UMLS CUI [1,1])
C0040732 (UMLS CUI [1,2])
Age
Item
males and females ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Left ventricular ejection fraction
Item
left ventricular ejection fraction (lvef) ≥ 40%
boolean
C0428772 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Waldenstrom Macroglobulinemia
Item
waldenstrom macroglobulinemia
boolean
C0024419 (UMLS CUI [1])
Amyloidosis
Item
known amyloidosis
boolean
C0002726 (UMLS CUI [1])
Leukemia, Plasma Cell
Item
plasma cell leukemia
boolean
C0023484 (UMLS CUI [1])
POEMS Syndrome
Item
poems syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes)
boolean
C0085404 (UMLS CUI [1])
Neuropathy CTCAE Grades
Item
significant neuropathy (grades ≥ 2) within 14 days prior to randomization
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial